This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Achyranthes root contains active compounds including ecdysterone, oleanolic acid, and saponins that contribute to its therapeutic effects. In Traditional Chinese Medicine, it works by invigorating blood circulation and directing energy downward, which helps strengthen tendons and bones. Ecdysterone has been studied for potential anabolic and bone-protective properties. The herb's downward-directing action makes it particularly useful for conditions affecting the lower body, such as lumbar pain and knee weakness. Evidence level: C.
Does Achyranthes root interact with blood thinners or anticoagulants?
Yes, Achyranthes root should be used with caution alongside anticoagulant or antiplatelet medications. As a blood-invigorating herb, it promotes blood circulation and may enhance the effects of blood-thinning drugs, potentially increasing bleeding risk. Patients taking warfarin, aspirin, clopidogrel, or similar medications should consult a qualified healthcare provider before using Achyranthes. Close monitoring may be necessary if combined use is deemed appropriate. Evidence level: C.
What is the recommended dosage for Achyranthes bidentata?
The typical adult dosage for Achyranthes root is 6-15 grams when prepared as a decoction, or approximately 500mg of standardized extract taken twice daily. Dosage may vary based on the specific condition being treated, the formulation used, and individual factors. In Traditional Chinese Medicine, it is often combined with other herbs in formulations tailored to the patient. Always follow the guidance of a qualified practitioner, as higher doses may increase the risk of side effects such as gastrointestinal upset.
Is Achyranthes root safe to take during pregnancy?
No, Achyranthes root is contraindicated during pregnancy. This herb promotes blood circulation and directs energy downward, which can stimulate menstrual flow and potentially cause uterine contractions. These actions pose a significant risk of miscarriage or pregnancy complications. Women who are pregnant or attempting to conceive should avoid Achyranthes bidentata entirely. If pregnancy is suspected, discontinue use immediately and consult a healthcare provider.
What is Achyranthes root used for in Traditional Chinese Medicine?
Achyranthes root is primarily used to invigorate blood circulation, strengthen tendons and bones, and guide other herbs downward in the body. It is commonly prescribed for lumbar pain and weakness, joint problems in the lower extremities, menstrual irregularities including amenorrhea, and as a kidney tonic for lower back weakness. Some research suggests potential benefits for osteoporosis and joint health, though clinical evidence remains limited. Evidence level: C.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Achyranthes Root (Achyranthes bidentata), also known as Huai-Niu-Xi, is a traditional Chinese medicinal herb used primarily for its anti-inflammatory, antioxidant, and osteoprotective properties [PMID:38600792, 33711437].
Background
Achyranthes bidentata Blume is a plant of the Amaranthaceae family, where the root serves as the primary medicinal part [PMID:38600792, 39363520].
Traditional uses
Traditionally used as a diuretic, tonic, and remedy for blood stasis [PMID:34981406]. It is applied to treat amenorrhea, dysmenorrhea, waist and knee pain, muscle and bone weakness, stranguria, edema, headache, dizziness, toothache, oral aphthae, hematemesis, and epistaxis [PMID:42302952, 28347832].
Active compounds
The root contains over 270 metabolites, primarily terpenoids and steroids [PMID:38600792]. Key constituents include triterpene saponins (such as oleanolic acid saponins, chikusetsusaponins IVa and V, and achyranthosides B, C, D, E, and G) [PMID:34981406, 26439478], pectic polysaccharides [PMID:40550436, 37451376], graminan-type fructans [PMID:38823933], and phytoecdysteroids like Niuxixinsterone D [PMID:28033715]. Other identified active compounds include $\beta$-Ecdysone and Quercetin [PMID:40682943].
Mechanism of action
Mechanisms include scavenging reactive oxygen species (ROS) and inhibiting the JNK/FOXO1 pathway [PMID:41430692], regulating the JUN/CREB-cAMP signaling pathway to mitigate neuronal apoptosis [PMID:40682943], and activating the Keap1/Nrf2/HO-1 pathway [PMID:40550436]. It also modulates gut microbiota to increase short-chain fatty acids (SCFAs) [PMID:38823933, 41391795] and inhibits the TGF-$\beta$1/Smad3 pathway to reduce pulmonary fibrosis [PMID:40550436].
Clinical evidence
Evidence AOsteoporosis
Root extracts demonstrate osteoprotective effects in rats, improving bone mineral density and biomechanical parameters [PMID:39363520].
Evidence DRheumatoid Arthritis
Polysaccharides alleviate RA by modulating the gut microbiota-barrier-metabolite axis and reducing arthritis indices in murine models [PMID:41391795].
Evidence DDiabetic Kidney Disease
A graminan-type fructan (ABPW1) protected against kidney injuries and intestinal barrier disruption in diabetic mice [PMID:38823933].
Exosome-like nanovesicles (ABNVs) reduced cartilage degradation and synovial inflammation in rat models [PMID:41430692].
Evidence DMuscle Atrophy
Saponin extracts (ABSE) alleviate disuse-induced muscle atrophy via the PI3K/Akt signaling pathway in mice [PMID:37028612].
Safety & adverse effects
Oral toxicity and genotoxicity studies using hot water extract in SD rats and mice showed no significant adverse effects at doses up to 2000 mg/kg/day [PMID:33711437].
Evidence summary
The evidence is primarily based on in vitro studies and animal models (rats, mice, zebrafish), with one systematic review and meta-analysis supporting its use for osteoporosis in rats. Human clinical trial data is not provided in the abstracts.
PubMed sources
1.PMID: 40459062 (2025) — Astragalus Polysaccharide Hydrogels with Drug-Carrying Super Self-Assembly from Natural Herbs Promote Wound Healing. · ACS nano
2.PMID: 34981406 (2022) — Saponin constituents of Achyranthes root. · Journal of natural medicines
3.PMID: 38823933 (2024) — A graminan type fructan from Achyranthes bidentata prevents the kidney injury in diabetic mice by regulating gut microbiota. · Carbohydrate polymers
4.PMID: 41430692 (2025) — CAT/SOD-Enriched Achyranthes bidentata nanovesicles mitigate TMJOA via ROS scavenging and JNK/FOXO1 pathway Inhibition. · Journal of nanobiotechnology
5.PMID: 38600792 (2024) — Achyranthes bidentata Blume (Amaranthaceae): a review of its botany, traditional uses, phytochemistry, pharmacology, and toxicology.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 41498029 (2025) — Immunomodulatory Mechanisms of Rehmanniae Radix Praeparata-Achyranthes Root-Chinese Angelica Root Combination in Nontraumatic Osteonecrosis of the Femoral Head: A Comprehensive Network Pharmacology and Molecular Docking Study Focusing on Immunological Pathways. · Mediators of inflammation
7.PMID: 40682943 (2025) — Achyranthes Bidentata Radix mitigates neuronal apoptosis via regulation of JUN and CREB in the cAMP signaling pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
8.PMID: 40777991 (2025) — Effects and molecular mechanisms of Achyranthes bidentata Blume and Cyathula officinalis K.C. Kuan in the treatment of rheumatoid arthritis. · Frontiers in pharmacology
9.PMID: 28033715 (2017) — A new phytoecdysteroid from the roots of Achyranthes bidentata Bl. · Natural product research
10.PMID: 39363520 (2024) — Osteoprotective effect of Achyranthes bidentata root extract on osteoporotic rats: a systematic review and meta-analysis. · Pharmaceutical biology
11.PMID: 38765877 (2024) — Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Radix Rehmanniae Praeparata - Angelica Sinensis - Radix Achyranthis Bidentatae in Treating Knee Osteoarthritis. · Drug design, development and therapy
12.PMID: 38243389 (2024) — Oligo/polysaccharides from Cyathula officinalis and Achyranthes bidentata: a review of structures and bioactivities. · The Journal of pharmacy and pharmacology
13.PMID: 31823889 (2020) — Achyranthes bidentata polypeptides prevent apoptosis by inhibiting the glutamate current in cultured hippocampal neurons. · Neural regeneration research
14.PMID: 33711437 (2021) — Evaluation of oral toxicity and genotoxicity of Achyranthis Radix extract. · Journal of ethnopharmacology
15.PMID: 11724247 (2001) — Two triterpene saponins from Achyranthes bidentata. · Chemical & pharmaceutical bulletin
16.PMID: 40550436 (2025) — Novel pectic polysaccharide from Achyranthes bidentata regulates the TGF-β pathway and intestinal microbiota and displays anti-pulmonary fibrosis effects. · International journal of biological macromolecules
17.PMID: 31410108 (2019) — Effects of Achyranthes bidentata alcohol on proliferation capacity of osteoblasts and miRNA in Runx2. · Experimental and therapeutic medicine
18.PMID: 37451376 (2023) — A pectic polysaccharide isolated from Achyranthes bidentata is metabolized by human gut Bacteroides spp. · International journal of biological macromolecules
19.PMID: 41244813 (2025) — Achyranthes bidentata polysaccharides attenuate hypoxic renal injury by reducing neutrophil extracellular traps and suppressing the NLRP3/ASC/caspase-1 pathway: a preliminary study. · Frontiers in pharmacology
20.PMID: 37028612 (2023) — Saponin extract from Achyranthes bidentata Blume alleviates disuse-induced muscle atrophy through PI3K/Akt signaling pathway. · Journal of ethnopharmacology
21.PMID: 33366037 (2019) — Complete chloroplast genome of Achyranthes bidentata Blume. · Mitochondrial DNA. Part B, Resources
23.PMID: 37728585 (2024) — Perspectives on Osteoarthritis Treatment with Mesenchymal Stem Cells and Radix Achyranthis Bidentatae. · Aging and disease
24.PMID: 41391795 (2026) — Achyranthes bidentata polysaccharides alleviates rheumatoid arthritis via the gut microbiota-barrier-metabolite axis in vitro and in vivo. · International journal of biological macromolecules
25.PMID: 37832477 (2024) — Efficacy evaluation and metabolomics analysis of raw and salt-processed Achyranthes bidentata Radix in zebrafish larvae for osteoporosis treatment. · Journal of pharmaceutical and biomedical analysis
26.PMID: 42302952 (2026) — Achyranthis bidentatae radix: A comprehensive review of botany, processing methods, ethnopharmacology, phytochemistry, pharmacology, quality control, toxicity, and pharmacokinetics. · Journal of ethnopharmacology
27.PMID: 23754164 (2013) — Study of osteoporosis treatment principles used historically by ancient physicians in Chinese Medicine. · Chinese journal of integrative medicine
28.PMID: 28347832 (2017) — The genus Achyranthes: A review on traditional uses, phytochemistry, and pharmacological activities. · Journal of ethnopharmacology
29.PMID: 26439478 (2016) — LC-MS-based quantification method for Achyranthes root saponins. · Journal of natural medicines
30.PMID: 33796647 (2021) — The complete chloroplast genome of Achyranthes bidentata Blume. · Mitochondrial DNA. Part B, Resources